NECIA DALLEY: Open Payments
NPI 1124670872 · RIVERTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 16 payments from 11 companies in 2025. Trend: 2023 $286 · 2024 $300 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Corcept Therapeutics | 2 | $50 |
| SANOFI-AVENTIS U.S. LLC | 1 | $38 |
| PFIZER INC. | 2 | $30 |
| Neuronetics, Inc. | 1 | $30 |
| Boston Scientific Corporation | 1 | $17 |
| Biogen, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| Medtronic, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, Korlym, TZIELD, PREVNAR 20, NEUROSTAR TMS THERAPY SYSTEM, WaveWriter Alpha Prime 16, ZURZUVAE, INCEPTIV.
Industry payments across UT — which companies pay providers there.
